Short communication: Selective placental transport of maternal IgG to the fetus

被引:36
作者
Williams, PJ
Arkwright, PD
Rudd, P
Scragg, IG
Edge, CJ
Wormald, MR
Rademacher, TW
机构
[1] UNIV OXFORD, DEPT BIOCHEM, GLYCOBIOL INST, OXFORD OX1 3QU, ENGLAND
[2] UCL, SCH MED, DEPT MOLEC PATHOL, MOLEC MED UNIT, LONDON W1P 6DB, ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1016/0143-4004(95)90018-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
During pregnancy there is a dramatic reduction in the serum levels of agalactosyl IgG (GOIgG) in both normal women and those with rheumatoid arthritis. ln order to determine if a similar reduction in GOIgG were apparent in fetal serum, a comparison of the galactose content of IgG from nine paired samples of umbilical vein or fetal blood and peripheral maternal serum, at gestational ages ranging from 16-41 weeks was performed. The full-term maternal IgG samples were highly galactosylated, so confirming previous observations of reduced GOIgG levels during Pregnancy. In addition every palled sample of fetal Ige had a higher level of galactosylation than the corresponding maternal IgG. Therefore, during pregnancy there is both a reduced biosynthesis of the GOIgG glycoform by the mother, and a restriction of its transport across the placenta. The ratio of estimated GOIgG in fetal and maternal serum was found to be related to changes in IgG transport, and in particular the active transport of IgG(1) across the placenta during gestation. Our data suggest that the placental Ige transport mechanism is either carbohydrate independent by discriminating for IgG(1), or is carbohydrate dependent selecting for highly galactosylated IgG glycoforms. This study emphasizes the weed for further investigations on the biological function of GOIgG in normal physiological states, in addition to disease states, such as juvenile and adult rheumatoid arthritis, where elevated GOIgG levels correlate with disease activity.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 18 条
[1]  
Ashford, Dwek, Welply, Amatayakul, Homans, Lis, Taylor, Sharon, Rademacher, The β1-2-d-xylose and α1-3-l-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin, European Journal of Biochemistry, 166, pp. 311-320, (1987)
[2]  
Black, Plikaytis, Wells, Ramirez, Carlone, Chilmonezyk, Reimer, Two-site immunoenzymometric assay for serum IgG subclass infant/maternal ratios at full term, Journal of Immunological Methods, 106, pp. 71-81, (1988)
[3]  
Burmeister, Gastinel, Simister, Blum, Bjorkman, Crystal structure at 2.2A resolution of the MHC-related neonatal Fc receptor, Nature, 372, pp. 336-343, (1994)
[4]  
Burmeister, Huber, Bjorkman, Crystal structure of the complex of rat neonatal Fc receptor with Fc, Nature, 372, pp. 379-383, (1994)
[5]  
Heyman, Nose, Weigle, Carbohydrate chains on IgG<sub>2b</sub>: a requirement for efficient feedback immunosuppression, Journal of Immunology, 134, pp. 4018-4023, (1985)
[6]  
Hobbs, Jackson, Hoadley, Interaction of aglycosyl IgG with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering, Molecular Immunology, 29, pp. 949-956, (1992)
[7]  
Leatherbarrow, Rademacher, Dwek, Woof, Clark, Burton, Effector functions of a monoclonal aglycosylated mouse IgG<sub>2a</sub>: binding and activation of complement C1 and interaction with human monocyte Fc receptor, Molecular Immunology, 22, pp. 406-415, (1985)
[8]  
Nose, Wigzell, Biological significance of carbohydrate chains on monoclonal antibodies, Proceedings of the National Academy of Science, U.S.A., 80, pp. 6632-6636, (1983)
[9]  
Parekh, Dwek, Sutton, Fernandes, Leung, Stanforth, Rademacher, Mizuochi, Taniguchi, Matsuta, Takeuchi, Nagano, Miyamoto, Kobata, Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature, 316, pp. 452-457, (1985)
[10]  
Parekh, Isenberg, Ansell, Roitt, Dwek, Rademacher, Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis in relation to disease, Lancet, 30, pp. 966-969, (1988)